P5 (LILPKHSDAD) and P7 (LTFPGSAED) are two peptides from lupin protein that are absorbed in Caco-2 cells. Recent in silico docking studies had suggested that they could potentially function as inhibitors of 3-hydroxy-3-methylglutaryl CoA reductase (HMGCoAR) activity. This paper confirms that both peptides inhibit in vitro the HMGCoAR functionality and it reports the characterisation of the molecular mechanism through which they modulate the cholesterol metabolism in HepG2 cells. Through the inhibition of HMGCoAR activity, P5 and P7 are able to improve the LDLR protein levels leading to a better ability of HepG2 cells to uptake extracellular LDL molecules with a final hypocholesterolaemic effects. The modulation of PCSK9 intracellular processing was also evaluated: only P5 was able to decrease the PCSK9 and HNF1-alpha protein levels leading to a decrease of mature PCSK9 secretion by HepG2 cells.

Investigations on the hypocholesterolaemic activity of LILPKHSDAD and LTFPGSAED, two peptides from lupin β-conglutin : focus on LDLR and PCSK9 pathways / C. Zanoni, G. Aiello, A. Arnoldi, C. Lammi. - In: JOURNAL OF FUNCTIONAL FOODS. - ISSN 1756-4646. - 32(2017), pp. 1-8.

Investigations on the hypocholesterolaemic activity of LILPKHSDAD and LTFPGSAED, two peptides from lupin β-conglutin : focus on LDLR and PCSK9 pathways

C. Zanoni
Primo
;
G. Aiello
Secondo
;
A. Arnoldi
;
C. Lammi
Ultimo
2017

Abstract

P5 (LILPKHSDAD) and P7 (LTFPGSAED) are two peptides from lupin protein that are absorbed in Caco-2 cells. Recent in silico docking studies had suggested that they could potentially function as inhibitors of 3-hydroxy-3-methylglutaryl CoA reductase (HMGCoAR) activity. This paper confirms that both peptides inhibit in vitro the HMGCoAR functionality and it reports the characterisation of the molecular mechanism through which they modulate the cholesterol metabolism in HepG2 cells. Through the inhibition of HMGCoAR activity, P5 and P7 are able to improve the LDLR protein levels leading to a better ability of HepG2 cells to uptake extracellular LDL molecules with a final hypocholesterolaemic effects. The modulation of PCSK9 intracellular processing was also evaluated: only P5 was able to decrease the PCSK9 and HNF1-alpha protein levels leading to a decrease of mature PCSK9 secretion by HepG2 cells.
Bioactive peptides; Functional foods; LDL receptor; PCSK9; Plant protein; Food Science; Nutrition and Dietetics
Settore CHIM/10 - Chimica degli Alimenti
   Innovative functional foods based on sweet lupin protein for cardiovascular prevention
   LUPICARP
   EUROPEAN COMMISSION
   FP7
   285819
2017
Article (author)
File in questo prodotto:
File Dimensione Formato  
2017 Lammi JFF P5-P7.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1.17 MB
Formato Adobe PDF
1.17 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Lammi et al 2017 AV_P5and P7.pdf

accesso aperto

Tipologia: Post-print, accepted manuscript ecc. (versione accettata dall'editore)
Dimensione 985.77 kB
Formato Adobe PDF
985.77 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/482908
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 42
social impact